跳至主要内容
临床试验/NCT04459780
NCT04459780已完成不适用

Characterization and Functionality of Calcium Channels Cav1.4 of Th17 Lymphocytes in Human With Psoriasis

Pierre Fabre Dermo Cosmetique2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2016年10月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
Expression of Cav1.4 calcium channels in Th17 lymphocytes

研究概览

简要总结

It's clearly known that lymphocyte activation in particular Th17 response, plays a major role in the development of plaque psoriasis. New therapies targeting this pathway are showing great clinical efficacy in patients with moderate to severe plaque psoriasis.

Pioneering observations have shown that the expression of Cav1.4 channels in Th17 lymphocytes and they're functional role is supported by the inhibition of IL-17 production by a pharmacological inhibitor of Cav1 channels that is effective in a mouse model of Psoriasis.

This data strongly suggest that the Cav1.4 channel, via its involvement in the signalling responsible for the production of Th17 cytokines represents an interesting therapeutic target in Psoriasis.

The aim of the study is to explore biological functions related to the activation of the Cav1.4 pathway in Psoriasis.

详细描述

  • Evaluate the expression of Cav1.4 calcium channels by Th17 lymphocytes from plaque psoriasis.

  • To assess:

  • The role of Cav1.4 channels on the activation of Th17 lymphocytes

  • The transcriptomic signature relating to the signalling channel Cav1.4

  • The epigenetic signature, in particular changes in overall methylation and specific promoter methylation

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Group 1 : Subject with plaque psoriasis (diagnosis confirmed by dermatologist) with a plaque IGA score ≥ 3
  • Group 2 : Subject with atopic dermatitis according to the UK Working party criteria with an IGA plaque score ≥3
  • Exlusion Criteria:
  • Group 1 : Other chronic inflammatory dermatosis than plaque psoriasis at the sites to be sampled
  • Group 2 : Other chronic inflammatory dermatosis than Atopic Dermatitis at the sites to be sampled
  • For both groups: Ongoing treatment with calcium channel blockers
  • For both groups: Any current topical treatment on the biopsied or systemic plaque for psoriasis or AD (including phototherapy)

排除标准

  • 未提供

结局指标

主要结局

Expression of Cav1.4 calcium channels in Th17 lymphocytes

时间窗: Baseline

Immunohistochemistry (IHC) and in situ hybridation (HIS)

次要结局

  • Role of Cav1.4 channels on the activation of Th17 lymphocytes(Baseline)
  • Transcriptomic signature relating to the signaling channel Cav1.4(Baseline)
  • Epigenetic signature, in particular changes in overall methylation and specific promoter methylation(Baseline)

研究者

发起方
Pierre Fabre Dermo Cosmetique
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Characterization and Functionality of Calcium... | 临床试验